erucyl amide has been researched along with Lupus Erythematosus, Systemic in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Feng, N; Gu, S; Jiang, H; Liu, F; Lv, L; Yan, R; Zhang, N | 1 |
1 other study(ies) available for erucyl amide and Lupus Erythematosus, Systemic
| Article | Year |
|---|---|
Fecal Metabolites Were Altered, Identified as Biomarkers and Correlated With Disease Activity in Patients With Systemic Lupus Erythematosus in a GC-MS-Based Metabolomics Study.
Topics: Adult; Biomarkers; Disease Progression; Erucic Acids; Feces; Female; Gas Chromatography-Mass Spectrometry; Humans; Lupus Erythematosus, Systemic; Male; Metabolomics; Middle Aged; Phenols; ROC Curve; Valine | 2020 |